Nippon India Pharma Fund - Idcw Reinvestment Option

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Nippon India Pharma Fund - Idcw Reinvestment Option
Rating
Fund
Time to Invest
Nippon India Pharma Fund - Idcw Reinvestment Option
NAV
76.2551
(23/09/2022)
L 52Wk H
70.47
91.70
Login using to know what your Friends are Investing !

Nippon India Pharma Fund - Idcw Reinvestment Option

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Nippon India Pharma Fund - Idcw Reinvestment Option
Fund
NAV
76.2551
(23/09/2022)
Time to Invest
Nippon India Pharma Fund - Idcw Reinvestment Option
Rating
L 52Wk H
70.47
91.70

Asset Allocation for Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Top 10 Holdings of Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

68.98 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(14.21%)
Cipla LimitedCipla Limited(9.05%)
Dr. Reddy's Laboratories LimitedDr. Reddy's Laboratories Limited(7.87%)
Lupin LimitedLupin Limited(6.56%)
Torrent Pharmaceuticals LimitedTorrent Pharmaceuticals Limited(6.42%)
Divi's Laboratories LimitedDivi's Laboratories Limited(5.93%)
Narayana Hrudayalaya LimitedNarayana Hrudayalaya Limited(5.64%)
Abbott India LimitedAbbott India Limited(5.28%)
Aurobindo Pharma LimitedAurobindo Pharma Limited(4.16%)
Fortis Healthcare LimitedFortis Healthcare Limited(3.85%)

Detailed Portfolio of Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Portfolio Date -31 Aug 2022
Equity Holdings -28
Other Holdings -3
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 14.21% 652.014 Cr
Cipla Limited 9.05% 415.380 Cr
Dr. Reddy's Laboratories Limited 7.87% 360.829 Cr
Lupin Limited 6.56% 301.097 Cr
Torrent Pharmaceuticals Limited 6.42% 294.605 Cr
Divi's Laboratories Limited 5.93% 272.014 Cr
Narayana Hrudayalaya Limited 5.64% 258.925 Cr
Abbott India Limited 5.28% 242.344 Cr
Aurobindo Pharma Limited 4.16% 190.890 Cr
Fortis Healthcare Limited 3.85% 176.580 Cr
JB Chemicals & Pharmaceuticals Limited 3.29% 150.935 Cr
Gland Pharma Limited 3.10% 142.083 Cr
Sanofi India Limited 3.00% 137.710 Cr
Apollo Hospitals Enterprise Limited 2.83% 130.021 Cr
Zydus Lifesciences Limited 2.52% 115.420 Cr
Pfizer Limited 2.45% 112.362 Cr
Thyrocare Technologies Limited 2.38% 109.217 Cr
Ajanta Pharma Limited 2.15% 98.733 Cr
Alkem Laboratories Limited 1.83% 84.008 Cr
Vijaya Diagnostic Centre Limited 1.52% 69.739 Cr -
Indoco Remedies Limited 1.43% 65.791 Cr
IPCA Laboratories Limited 0.99% 45.340 Cr -
Rainbow Childrens Medicare Limited 0.80% 36.680 Cr -
Orchid Pharma Limited 0.68% 30.950 Cr
Tarsons Products Limited 0.57% 26.106 Cr -
GlaxoSmithKline Pharmaceuticals Limited 0.48% 21.866 Cr
Jubilant Pharmova Limited 0.42% 19.292 Cr
Healthcare Global Enterprises Limited 0.28% 12.648 Cr
Holdings % Weight Value Sahi Hai/Nahi
Triparty Repo 0.53% 24.490 Cr -
Cash Margin - CCIL 0.00% 0.155 Cr -
Net Current Assets -0.23% -10.474 Cr -

Insight on the composition of the Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Nippon India Pharma Fund - Idcw Reinvestment Option

Style Box of the Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Nippon India Pharma Fund - Idcw Reinvestment Option

Portfolio Characteristics of the Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Nippon India Pharma Fund - Idcw Reinvestment Option